☆ 4.6 Article

Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis

CANCERS (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Urology & Nephrology

International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma

Theo van der Kwast et al.

Summary: This article explores the requirements for an optimal grading system for non-muscle-invasive bladder cancer through expert opinion. It suggests splitting the WHO 2004 high-grade category into WHO 1973 grade 2 and 3 subsets, providing more detailed histological criteria. These changes may lead to better treatment decisions for patients with bladder cancer.

EUROPEAN UROLOGY FOCUS (2022)

添加到收藏夹

Article Pathology

Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study

Ekaterina Olkhov-Mitsel et al.

Summary: The study identified the immune environment associated with PD-L1 expression in high-grade urothelial carcinomas (HGUC) of the bladder using a transcriptomic approach. Results showed strong correlation between PD-L1 mRNA and protein expression, as well as enrichment of genes related to interleukin-10 production, lymphocyte chemotaxis, and aberrant signaling networks. Further investigation is warranted to explore the implications of these findings on immune evasion in HGUC.

JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma

Bohyun Kim et al.

Summary: Multiple mRNA-based classification systems for urinary bladder urothelial carcinoma (UB UC) have been reported, showing different treatment responses and prognoses for each molecular subtype. In this study, immunohistochemistry (IHC) was used to classify UB UC into different subgroups based on CK5/6 and CK20 expression. The CK5/6 positive subgroup exhibited a gene expression signature related to aggressive behavior and worse clinical outcome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Oncology

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

Antonio Lopez-Beltran et al.

Summary: Several immune checkpoint inhibitors have been approved for the treatment of patients with metastatic urothelial carcinoma, showing promising efficacy in first-line or second-line therapy. PD-L1 expression may be a predictive factor for response to ICIs. Anti-PD-1 and PD-L1 antibodies have demonstrated durable responses in some mUC patients.

CANCERS (2021)

添加到收藏夹

Article Pathology

Comprehensive pathological assessment of histological subtypes, molecular subtypes based on immunohistochemistry, and tumor-associated immune cell status in muscle-invasive bladder cancer

Junichi Ikeda et al.

Summary: This study retrospectively analyzed 106 patients with muscle-invasive bladder cancer who underwent radical cystectomy. The findings showed a high association of urothelial carcinoma with squamous differentiation and the sarcomatoid variant with the basal molecular subtype, and a significant correlation between high TAICs and the basal subtype, with TAICs effectively discriminating cancer-specific survival rates.

PATHOLOGY INTERNATIONAL (2021)

添加到收藏夹

Article Urology & Nephrology

Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab

Andrea Necchi et al.

Summary: The study found significant molecular subtype changes in MIBC tumors after pembrolizumab treatment, with some tumors showing scar-like characteristics. This scar-like subtype exhibited higher luminal marker expression post-pembrolizumab. Patients with the scar-like subtype showed better prognosis after systemic therapy.

EUROPEAN UROLOGY (2021)

添加到收藏夹

Review Pathology

Molecular pathology of urothelial carcinoma

Antonio Lopez-Beltran et al.

Summary: The current era of personalized oncology has seen significant efforts to integrate clinical, pathological, and molecular classifications. The rich knowledge on the molecular basis of bladder cancer has led to a novel approach incorporating molecularly generated data in clinical practice. Translational research has provided insights into the early events in the development of urothelial carcinoma, showing that mutations in certain genes drive cells to colonize larger regions of the urothelium and trigger malignant transformation.

HUMAN PATHOLOGY (2021)

添加到收藏夹

Article Pathology

Fibroblast growth factor receptor (FGFR) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder

Khaleel Al-Obaidy et al.

Summary: Dysregulation of FGFR pathway is associated with urothelial carcinoma, with common activating somatic mutations of FGFR3 clustered in three hotspots. The FDA approved the first targeted FGFR therapy, erdafitinib, for locally advanced or metastatic bladder cancer patients who have progressed on platinum-based chemotherapy, marking a significant milestone in the treatment of this disease.

JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹

Review Oncology

Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing

Antonio Lopez-Beltran et al.

Summary: The workshops aimed to develop recommendations for best practice approaches to PD-L1 testing in UC, emphasizing the importance of robust control of analytical standards, clear communication for interpretation and reporting of PD-L1 results. In addition, a test request form for pathology laboratories was developed to facilitate communication between clinicians and pathologists for fast and high-quality test results. Novel biomarkers for immuno-oncology agents in UC were briefly discussed in the era of personalized medicine.

CANCERS (2021)

添加到收藏夹

Article Oncology

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer

Jeffrey S. Damrauer et al.

Summary: This study suggests that assessment of the immune tumor microenvironment (TME) may serve as a promising predictive biomarker of response to BCG treatment in NMIBC. Expression of immune checkpoint genes is associated with an inflamed TME, but not with higher recurrence rates after BCG. The study highlights the importance of modulating the TME in an immunologically cold tumor for further investigation.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Urology & Nephrology

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort

Veronika Weyerer et al.

Summary: Recently discovered molecular classifications for urothelial bladder cancer may not serve as reliable prognostic or predictive biomarkers. Both gene and protein-based subtyping methods did not show significant associations with disease-specific or recurrence-free survival in this study. However, there is some agreement between gene expression and protein-based subtyping, and histological subtypes may play a role in single-variable survival analysis.

WORLD JOURNAL OF UROLOGY (2021)

添加到收藏夹

Article Oncology

Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study

Bas W. G. van Rhijn et al.

Summary: The study compared the prognostic value of WHO1973 and WHO2004/2016 classification systems in non-muscle invasive bladder cancer patients, showing that WHO1973 had a higher predictive value for progression compared to WHO2004/2016, while both systems were not significantly predictive for recurrence. The combined use of both systems can better stratify patients and improve the accuracy of prognosis prediction.

EUROPEAN UROLOGY ONCOLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

Aurelie Kamoun et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Article Urology & Nephrology

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Andrea Necchi et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Review Pathology

Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy

Hikmat Al-Ahmadie et al.

ADVANCES IN ANATOMIC PATHOLOGY (2020)

添加到收藏夹

Article Pathology

Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer Progress and Challenges

Joshua Warrick et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

添加到收藏夹

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes

Huili Li et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Oncology

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy

Tician Schnitzler et al.

CELLULAR ONCOLOGY (2020)

添加到收藏夹

Article Urology & Nephrology

Genomic Subtyping in Bladder Cancer

Tuomas Jalanko et al.

CURRENT UROLOGY REPORTS (2020)

添加到收藏夹

Review Urology & Nephrology

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Joshua J. Meeks et al.

NATURE REVIEWS UROLOGY (2020)

添加到收藏夹

Article Urology & Nephrology

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

A. Gordon Robertson et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Article Urology & Nephrology

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Andrea Necchi et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Review Oncology

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

Veronica Mollica et al.

CANCERS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Assessment of Luminal and Basal Phenotypes in Bladder Cancer

Charles C. Guo et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands

Daan J. Reesink et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development and validation of a NanoString BASE47 bladder cancer gene classifier

Jordan Kardos et al.

PLOS ONE (2020)

添加到收藏夹

Article Urology & Nephrology

Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants

Joshua I. Warrick et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Article Urology & Nephrology

The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability

Jaegil Kim et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Review Urology & Nephrology

Clinical implications of molecular subtyping in bladder cancer

Uttam Satyal et al.

CURRENT OPINION IN UROLOGY (2019)

添加到收藏夹

Article Pathology

Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype

Jorge Rebola et al.

VIRCHOWS ARCHIV (2019)

添加到收藏夹

Article Pathology

Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder

Maria Del Carmen Rodriguez Pena et al.

VIRCHOWS ARCHIV (2019)

添加到收藏夹

Review Urology & Nephrology

Predictive biomarkers for drug response in bladder cancer

Takahiro Yoshida et al.

INTERNATIONAL JOURNAL OF UROLOGY (2019)

添加到收藏夹

Review Cell Biology

Staging of bladder cancer

Martin J. Magers et al.

HISTOPATHOLOGY (2019)

添加到收藏夹

Review Cell Biology

Variants and new entities of bladder cancer

Antonio Lopez-Beltran et al.

HISTOPATHOLOGY (2019)

添加到收藏夹

Review Oncology

Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts

Gottfrid Sjodahl et al.

JOURNAL OF PATHOLOGY (2019)

添加到收藏夹

Article Cell Biology

Basal-subtype bladder tumours show a hot' immunophenotype

Anjelica Hodgson et al.

HISTOPATHOLOGY (2018)

添加到收藏夹

Editorial Material Urology & Nephrology

Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation?

Cyrill A. Rentsch et al.

EUROPEAN UROLOGY (2017)

添加到收藏夹

Article Urology & Nephrology

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

Roland Seiler et al.

EUROPEAN UROLOGY (2017)

添加到收藏夹

Article Oncology

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification

Gottfrid Sjodahl et al.

JOURNAL OF PATHOLOGY (2017)

添加到收藏夹

Article Oncology

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency

Carolyn D. Hurst et al.

CANCER CELL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

CELL (2017)

添加到收藏夹

Article Oncology

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

Jakob Hedegaard et al.

CANCER CELL (2016)

添加到收藏夹

Article Urology & Nephrology

A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

David J. McConkey et al.

EUROPEAN UROLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

Vipulkumar Dadhania et al.

EBIOMEDICINE (2016)

添加到收藏夹

Article Genetics & Heredity

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

Brett Wallden et al.

BMC MEDICAL GENOMICS (2015)

添加到收藏夹

Article Oncology

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Woonyoung Choi et al.

CANCER CELL (2014)

添加到收藏夹

Review Oncology

Biomarkers in bladder cancer: Translational and clinical implications

Liang Cheng et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

Jeffrey S. Damrauer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

添加到收藏夹

Article Cell Biology

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

Sandra Rebouissou et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

添加到收藏夹

Article Oncology

A Molecular Taxonomy for Urothelial Carcinoma

Gottfrid Sjodahl et al.

CLINICAL CANCER RESEARCH (2012)

添加到收藏夹

Article Pathology

Histologic grading of urothelial carcinoma: a reappraisal

Liang Cheng et al.

HUMAN PATHOLOGY (2012)

添加到收藏夹

Review Oncology

The origins of urothelial carcinoma

Liang Cheng et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.